Oncology & Cancer

Blood test for brain cancer may be on horizon, research finds

Glioblastoma (GBM) is the most common and deadliest type of brain cancer with a five-year survival rate of only 5%. Researchers at Penn State College of Medicine have identified a biomarker that can be used in blood tests ...

Medications

COVID-19 drug Paxlovid may interact with common heart medications

Heart disease patients with symptomatic COVID-19 are often treated with nirmatrelvir-ritonavir (Paxlovid) to prevent progression to severe disease; however, it can interact with some previously prescribed medications. A review ...

Genetics

How well do boosters work? Depends on your genes

Genetics play an important role in how our bodies respond to vaccines and booster shots, suggesting that certain protective responses elicited by vaccination could be more effective with personalization, according to a new ...

Medical research

6 COVID-19 treatments helping patients survive

A year ago, when U.S. health authorities issued their first warning that COVID-19 would cause severe "disruption to everyday life," doctors had no effective treatments to offer beyond supportive care.

Diseases, Conditions, Syndromes

In recovering COVID-19 patients, antibodies fade quickly

In the absence of approved, effective treatments for COVID-19, some hospitals have been treating patients with severe COVID symptoms with blood plasma from recovering patients. The blood of recovered patients contains antibodies ...

Diabetes

Routine blood tests could predict diabetes

Random plasma glucose tests could be used to predict which patients will develop diabetes, according to a study of Veterans Affairs treatment data. Researchers from several VA systems showed that levels of glucose found during ...

page 2 from 7